Keros Therapeutics (KROS) Revenue (2019 - 2025)
Keros Therapeutics (KROS) posted Revenue of $385,000 for Q4 2025, down 87.3% from $3.04 million a year earlier and down 97.3% from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) Revenue (2019 - 2025) Analysis & Trends
For FY2025, Keros Therapeutics' Revenue came in at $244.06 million.
- Annual Revenue shows a four-year compound annual growth rate of 86.7% (FY2021 to FY2025).
- In prior years, Keros Therapeutics' Revenue was $3.55 million in FY2024, $151,000 in FY2023 and $20.1 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Revenue since Q2 2024.
- According to Business Quant data, Revenue for the three prior quarters was $14.26 million (Q3 2025), $18.17 million (Q2 2025) and $211.25 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.69 Bn | 1,103.27 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 616.29 Bn | 534.82 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 500.86 Bn | 473.97 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.77 Bn | 321.15 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.52 Bn | 190.92 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.49 Bn | 164.69 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Keros Therapeutics | 221.57 Mn | -1.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 385,000.00 |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 18.17 Mn |
| Mar 31, 2025 | 211.25 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 20.00 Mn |
| Jun 30, 2021 | 100,000.00 |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 2.50 Mn |
| Mar 31, 2019 | 2.50 Mn |
API Access
Keros Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();